{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-074421","form_type":"8-K","ticker":"CVKD","cik":"0001937993","company_name":"Cadrenal Therapeutics, Inc.","filed_at":"2026-07-01T21:23:30+00:00","discovered_at":"2026-07-01T21:26:00.362930+00:00","generated_at":"2026-07-01T21:27:21.008977+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cadrenal Therapeutics raises $3M in private placement; warrants add up to $5.8M","bullets":["Gross proceeds of $3M from sale of 960,000 pre-funded warrants at $3.1249/unit.","Issued series C-1 and C-2 warrants to purchase up to 960,000 shares each at $3.00.","Net proceeds to extend cash runway into Q1 2027; if warrants fully exercised, into H2 2027.","H.C. Wainwright acted as exclusive placement agent; officers/directors subject to 60-day lock-up.","Private placement closed July 1, 2026; securities unregistered, resale registration to be filed."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-074421","json":"https://secwatch.observer/filing/0001213900-26-074421.json","markdown":"https://secwatch.observer/filing/0001213900-26-074421.md","text":"https://secwatch.observer/filing/0001213900-26-074421.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026074421/0001213900-26-074421-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026074421/ea0296666-8k_cadrenal.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-01T21:27:21.008977+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}